Network News

The partnership combines Secarna’s OligoCreator® platform with VERAXA’s technology suite to create next-generation targeted therapies for autoimmune and inflammatory diseases. ZURICH,SWITZERLAND, and MARTINSRIED/MUNICH, GERMANY – September 30, 2025 — VERAXA Biotech, an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH,“Voyager”), and Secarna Pharmaceuticals GmbH & Co. KG, a company […]

Prestigious award for the developer of the first approved drug against hepatitis D On September 18, Prof. Dr. Dr. h.c. Stephan Urban, DZIF Professor of Translational Virology at Heidelberg University’s Medical Faculty, was honored with the McGuigan Award for Distinguished Work in Drug Discovery. The prize, worth £10,000, recognizes Urban’s outstanding scientific achievement and the […]

First pivotal Phase III study exPDite-2 for allogeneic pluripotent stem cell therapy Bemdaneprocel initiated / Phase II gene therapy study REGENERATE-PD with AB-1005 initiated in the United Kingdom and Poland, Germany to follow soon and continuing in the US / Parkinson’s disease is the second most common and fastest growing neurodegenerative disease, affecting more than […]

State of Baden-Württemberg funds the intensifying of existing cooperative relations with ten million euros On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. Prof. Dr Alan M. Garber, President of Harvard University, and Prof. Dr Frauke Melchior, Rector of […]

The shortlist of the Cancer Grand Challenges selection process 2025 has been announced and Roman Sarott, Research Group Leader at the Max Planck Institute for Medical Research, Heidelberg and Heilbronn, has been selected for the final stages as part of team NeoCircuit. The team tackles the challenge of developing and applying novel ways to rewire cancer […]

German Arthrosis Aid Association supports Heidelberg project for the treatment of chronic arthrosis pain With funding of €500,000, Deutsche Arthrose-Hilfe e.V. is supporting research into chronic osteoarthritis pain at Heidelberg University’s Medical Faculty. The aim of the funding is to scientifically evaluate a data set on patients with chronic pain that has been compiled over […]

The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]

aimed analytics GmbH has successfully closed its first funding round, raising a six-digit investment. At the same time, the company has completed the acquisition of ValueData GmbH, further strengthening its position as a pioneer in AI-driven biomedical data analytics. “Our mission is clear: to shape the future of medicine through the power of data analytics. […]

Alumnus Bastian Linder discusses the origin of this start-up and how a tRNA mechanism is helping scientists understand the importance and use of various RNA modifications as they pertain to disease. With just two dots above a letter, the German umlaut can instantly change a word’s pronunciation, its quantity (singular to plural), or even its […]